Bio-Rad Laboratories Total Current Liabilities 2010-2025 | BIO
Bio-Rad Laboratories total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Bio-Rad Laboratories total current liabilities for the quarter ending March 31, 2025 were $0.507B, a 8.68% increase year-over-year.
- Bio-Rad Laboratories total current liabilities for 2024 were $0.468B, a 10.52% decline from 2023.
- Bio-Rad Laboratories total current liabilities for 2023 were $0.523B, a 8.07% decline from 2022.
- Bio-Rad Laboratories total current liabilities for 2022 were $0.569B, a 16.48% decline from 2021.
| Bio-Rad Laboratories Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $468 |
| 2023 | $523 |
| 2022 | $569 |
| 2021 | $681 |
| 2020 | $632 |
| 2019 | $905 |
| 2018 | $451 |
| 2017 | $503 |
| 2016 | $471 |
| 2015 | $441 |
| 2014 | $447 |
| 2013 | $487 |
| 2012 | $472 |
| 2011 | $459 |
| 2010 | $667 |
| 2009 | $420 |
| Bio-Rad Laboratories Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $507 |
| 2024-12-31 | $468 |
| 2024-09-30 | $498 |
| 2024-06-30 | $487 |
| 2024-03-31 | $466 |
| 2023-12-31 | $523 |
| 2023-09-30 | $558 |
| 2023-06-30 | $582 |
| 2023-03-31 | $590 |
| 2022-12-31 | $569 |
| 2022-09-30 | $571 |
| 2022-06-30 | $614 |
| 2022-03-31 | $648 |
| 2021-12-31 | $681 |
| 2021-09-30 | $650 |
| 2021-06-30 | $587 |
| 2021-03-31 | $610 |
| 2020-12-31 | $632 |
| 2020-09-30 | $987 |
| 2020-06-30 | $927 |
| 2020-03-31 | $869 |
| 2019-12-31 | $905 |
| 2019-09-30 | $434 |
| 2019-06-30 | $446 |
| 2019-03-31 | $444 |
| 2018-12-31 | $451 |
| 2018-09-30 | $453 |
| 2018-06-30 | $442 |
| 2018-03-31 | $456 |
| 2017-12-31 | $503 |
| 2017-09-30 | $466 |
| 2017-06-30 | $455 |
| 2017-03-31 | $408 |
| 2016-12-31 | $471 |
| 2016-09-30 | $443 |
| 2016-06-30 | $410 |
| 2016-03-31 | $401 |
| 2015-12-31 | $441 |
| 2015-09-30 | $435 |
| 2015-06-30 | $404 |
| 2015-03-31 | $417 |
| 2014-12-31 | $447 |
| 2014-09-30 | $504 |
| 2014-06-30 | $480 |
| 2014-03-31 | $481 |
| 2013-12-31 | $487 |
| 2013-09-30 | $463 |
| 2013-06-30 | $431 |
| 2013-03-31 | $447 |
| 2012-12-31 | $472 |
| 2012-09-30 | $434 |
| 2012-06-30 | $417 |
| 2012-03-31 | $444 |
| 2011-12-31 | $459 |
| 2011-09-30 | $415 |
| 2011-06-30 | $443 |
| 2011-03-31 | $428 |
| 2010-12-31 | $667 |
| 2010-09-30 | $411 |
| 2010-06-30 | $389 |
| 2010-03-31 | $398 |
| 2009-12-31 | $420 |
| 2009-09-30 | $416 |
| 2009-06-30 | $384 |
| 2009-03-31 | $356 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.823B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
| Boston Scientific (BSX) | United States | $151.510B | 37.93 |
| Stryker (SYK) | United States | $148.668B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
| Medtronic (MDT) | Ireland | $113.608B | 16.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.623B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
| Agilent Technologies (A) | United States | $34.375B | 22.41 |
| Terumo (TRUMY) | Japan | $24.785B | 32.19 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $20.867B | 81.91 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
| Baxter (BAX) | United States | $15.734B | 11.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
| Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
| Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
| Haemonetics (HAE) | United States | $3.650B | 16.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.415B | 28.38 |
| ICU Medical (ICUI) | United States | $3.262B | 24.05 |
| QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
| LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| Acuren (TIC) | United States | $1.379B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
| Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
| Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
| Neogen (NEOG) | United States | $1.137B | 14.56 |
| BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
| InMode (INMD) | Israel | $0.971B | 9.78 |
| Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Owens & Minor (OMI) | United States | $0.695B | 5.76 |
| Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Evolus (EOLS) | United States | $0.597B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| SNDL (SNDL) | Canada | $0.363B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Quanterix (QTRX) | United States | $0.327B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
| Cerus (CERS) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.268B | 12.19 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
| Brainsway (BWAY) | Israel | $0.243B | 64.35 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.47 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Jin Medical (ZJYL) | China | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.57 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |